Cigna Corporation CI NYSE

Cigna Corporation (CI) has shown strong revenue growth over the past 3 years, expanding from $180.0B to $275.0B (average +15.4%/yr). Net income reached $6.0B, reflecting solid earnings growth at +5.7%/yr on average. The net profit margin is 2.2%, which is thin. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 9.5% (low), with a -72.9pp trend over the period. With a $73B market cap and MOAT composite score of 38/100, the company has a low competitive position.

Criteria proven by this page:

• GROWTH (73/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 39 of 41 years — an excellent long-term track record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (38/100, Fail) — limited competitive moat based on margins and scale

Overall SharesGrow Score: 62/100 with 4/7 criteria passed.